Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethosuximide for abdominal pain in irritable bowel syndrome
2016-002110-42Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ethosuximide in irritable bowel syndrome (IBS), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Treatment responder rate. Started May 2019; status: completed.
02
Drugs
ethosuximide
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on 2016-002110-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002110-42.